OTTLIV announces winners of first Innovation Trophies from AP-HP
3 July 2012
OTTLIV, the technology transfer arm of one of Assistance
Publique-Hopitaux de Paris (AP-HP), has announced the results of the
first “Innovation Trophies” for the hospitals' researchers.
Designed to mark outstanding promise resulting from research within
AP-HP, the Trophies will be awarded annually to one patent holder
and one start-up. The first awards were made during the ninth
APinnov, the technology transfer conference.
The “Promising Patent” award went to Antoine Carpentier, Hopital
Avicenne, for his research on cerebral tumours. The “Promising
Start-up” Trophy was awarded to his brother, Alexandre Carpentier,
from the Hopital Salpetriere, founder of Carthera, a developer of
therapeutic ultrasound devices and intra-articular ultrasound
The awards were organized jointly between AP-HP, CDC Entreprises,
an arm of the French government’s Caisse des Depots, investing in
more than 3,000 small and medium companies in France, and INPI,
France’s intellectual property and patent office.
AP-HP brings together 37 Paris hospitals, including university
and teaching establishments, and enjoys close associations with
world-famous bodies such as Inserm, the CNRS, the Institut Curie,
the Institut Gustav Roussy, the Institut Pasteur, and France’s
nuclear energy agency (CEA).
Originally, 45 companies were considered for the “Promising
Start-up” award. Ten made the shortlist, of which three were
nominated, including Carthera, BLK Pharma (new therapies for
attention deficit disorder), founded by Eric Konofal from the
Hopital Robert Debre, and Profilome (in vitro detection of
colorectal cancer using genetic markers), created by Iradj Sobhani,
Hôpital Henri Mondor.
From 115 patents considered, 10 were short-listed and three
nominated including Antoine Carpentier, Jacques Hugon from Hopital
Lariboisiere (new marker for Alzheimer’s) and Jean-Francois Emile,
Hopital Ambroise Pare (evaluation of malignancy and efficacy
prediction for tumor therapy).
The APinnov annual business convention aims to showcase
AP-HP-originated innovations and to encourage the transfer of
medical technology so as to continue improvement in the quality of
hospital care. The 2012 APinnov brought together 480 participants,
including many from industry and support organizations (investors,
incubators, financiers etc). Some 80 business meetings were
“Now we have established these Innovation Trophies, we want to
give all the encouragement we can to entrepreneurs and project
leaders from AP-HP so as to create a new generation of viable
enterprises that will stay the course,” said Florence Ghrenassia,
director of OTTLIV. “The awards will raise their profile and help
generate support from a variety of sources including early stage
financing and intellectual property advice, all of which will help
them deploy their talents and, we hope, enjoy a flourishing
“The variety of innovations and patents coming out of AP-HP is
unbelievable,” said Annick Schwebig, president of the Innovation
Trophies jury. “It is a highly diversified source of new tools and
treatments for future patients.”
The jury was made up of seven experts from different domains.
Schwebig has a distinguished career in healthcare including current
positions as chairperson of Actelion, representative of the Paris
chamber of commerce and industry, president of the biotech group at
LEEM (France’s medical industry association), and general secretary
of ARIIS, an association for health research.